Cargando…

Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics

BACKGROUND: In this study, we performed a molecular evaluation of primary pancreatic adenocarcinoma (PAAD) based on the comprehensive analysis of energy metabolism-related gene (EMRG) expression profiles. METHODS: Molecular subtypes were identified by nonnegative matrix clustering of 565 EMRGs. An o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Cong, Wang, Xin, Wang, Xu, Weng, Weiwei, Ni, Shu-juan, Zhang, Meng, Jiang, Hesheng, Wang, Lei, Huang, Dan, Sheng, Weiqi, Xu, Mi-die
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006543/ https://www.ncbi.nlm.nih.gov/pubmed/35418066 http://dx.doi.org/10.1186/s12885-022-09487-3

Ejemplares similares

Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes
por: Chang, Jin-Jia, et al.
Publicado: (2022)

Development and validation of a DNA repair gene signature for prognosis prediction in Colon Cancer
por: Wang, Xin, et al.
Publicado: (2020)

GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer
por: Sun, Hui, et al.
Publicado: (2020)

Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy
por: Xu, Midie, et al.
Publicado: (2022)

Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma
por: Zhang, Qiongyan, et al.
Publicado: (2019)

Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity
por: Huang, Dan, et al.
Publicado: (2019)

miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA
por: Ni, Shujuan, et al.
Publicado: (2018)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

Clinicopathological features and prognosis of AFP-producing colorectal cancer: a single-center analysis of 20 cases
por: Ren, Fei, et al.
Publicado: (2019)

Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
por: Sun, Hui, et al.
Publicado: (2022)

Hedgehog Interacting Protein 1 is a Prognostic Marker and Suppresses Cell Metastasis in Gastric Cancer
por: Sun, Hui, et al.
Publicado: (2018)

Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
por: Ni, Shujuan, et al.
Publicado: (2022)

A Lipid Metabolism-Based Seven-Gene Signature Correlates with the Clinical Outcome of Lung Adenocarcinoma
por: Li, Tianqi, et al.
Publicado: (2022)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Programmed death‐ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2‐negative status
por: Wang, Lei, et al.
Publicado: (2018)

Emerging roles of long non-coding RNAs in tumor metabolism
por: Sun, Hui, et al.
Publicado: (2018)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections
por: Ye, Min, et al.
Publicado: (2020)

Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma
por: Xu, Xiang, et al.
Publicado: (2022)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma
por: Wang, Fangqing, et al.
Publicado: (2023)

Long Non-Coding RNA LSINCT5 Predicts Negative Prognosis and Exhibits Oncogenic Activity in Gastric Cancer
por: Xu, Mi-Die, et al.
Publicado: (2014)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer
por: Zu, Fuqiang, et al.
Publicado: (2020)

A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data
por: Shi, Xiu-Hui, et al.
Publicado: (2018)

Human Papillomavirus-Associated Lymphoepithelioma-Like Carcinoma of the Anal Canal: A Case Report and Literature Review
por: Weng, Weiwei, et al.
Publicado: (2021)

Low expression of LOC285194 is associated with poor prognosis in colorectal cancer
por: Qi, Peng, et al.
Publicado: (2013)

Single Cell RNA-Seq Identifies Immune-Related Prognostic Model and Key Signature-SPP1 in Pancreatic Ductal Adenocarcinoma
por: Chen, Kai, et al.
Publicado: (2022)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma
por: Zhou, Chenhao, et al.
Publicado: (2019)

Potential four-miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co-expression analysis
por: You, Lukuan, et al.
Publicado: (2019)

A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
por: Li, Tiandong, et al.
Publicado: (2023)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d3kaj7eqhacqj7ftl387msu8pf